RNTX: Rein Therapeutics Inc. Stock

by  •  • Comments Off on RNTX: Rein Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 36.29
Enterprise Value ($M) 68.43
Book Value ($M) 54.39
Book Value / Share 2.47
Price / Book 0.67
NCAV ($M) 5.86
NCAV / Share 0.27
Price / NCAV 6.19

Profitability (mra)
Return on Invested Capital (ROIC) -1.16
Return on Assets (ROA) -0.63
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 2.38
Current Ratio 2.38

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -28.11
Net Income n/a
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -22.29
Cash from Investing 0.00
Cash from Financing 17.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-05 13G/A University Of Texas/texas Am Investment Managment Co 4.40 -47.00
2024-04-16 13D/A Satter Muneer A 4.90 -18.34

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 3,247 7,071 45.92
2025-04-16 4,410 16,240 27.16
2025-04-15 552 10,259 5.38
2025-04-14 243 10,061 2.42

(click for more detail)

Similar Companies
RGLS – Regulus Therapeutics Inc. RMTI – Rockwell Medical, Inc.
RNAZ – TransCode Therapeutics, Inc. RNXT – RenovoRx, Inc.
RVPH – Reviva Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io